Nektar's PEGylation reagent manufacturing business
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Nektar's PEGylation reagent manufacturing business - overview
Location
-, -, US
Primary Industry
Biotechnology
About
Based in the US, Nektar's PEGylation Reagent Manufacturing Business is a manufacturing company that specializes in developing, producing, and supplying activated polyethylene glycol (PEG) derivatives and related products. In December 2024, Ampersand Capital Partners acquired Nektar's PEGylation reagent manufacturing business from Nektar for USD 90 million. The business unit includes a commercial-scale specialized manufacturing facility in Huntsville, Alabama, with supporting commercial supply chains for PEGylated therapeutics. The facility has a range of commercial-scale supply chain contracts with leading pharmaceutical companies.
Current Investors
Ampersand
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy
Verticals
Manufacturing
Total Amount Raised
Subscriber access only
Nektar's PEGylation reagent manufacturing business - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Spin-Off | Completed | Nektar's PEGylation reagent manufacturing business | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.